Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Variables associated with patient activation in persons with multiple sclerosis.
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Alteration of CD1 expression in multiple sclerosis.
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Naltrexone prescribing information
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.

Pages